Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Mol Biol ; 335(4): 971-85, 2004 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-14698292

RESUMO

The E6 oncoprotein derived from the tumour-associated human papillomavirus (HPV) types induces the ubiquitin-mediated degradation of several cellular proteins by conjugating them with the cellular ubiquitin ligase E6-AP. This is a HECT domain-containing ligase that was originally identified through its involvement in the E6-mediated degradation of the cellular tumour suppressor protein p53. Here we have investigated, in more detail, the nature of the E6/E6-AP interaction using binding peptides isolated from an E6-specific library. The selected peptides were either predicted or shown to have an alpha-helical core resembling the E6-binding motif on E6-AP, as well as amino acid alterations that increased their affinity for E6. These peptides were potent inhibitors of the E6/E6-AP interaction. Further analysis of the effects of these peptides on the ability of E6 to direct the proteolytic degradation of its various substrates, including p53, Dlg and the MAGI family of proteins, as well as using E6-AP immunodepletion, revealed striking differences in the mechanism by which E6 targets its cellular substrates for degradation. These results suggest that the site on E6 bound by E6-AP is also most likely occupied by other, as yet unidentified, ubiquitin ligases.


Assuntos
Proteínas de Ligação a DNA , Inibidores Enzimáticos/farmacologia , Proteínas Oncogênicas Virais/antagonistas & inibidores , Proteínas Oncogênicas Virais/metabolismo , Peptídeos/farmacologia , Proteínas Repressoras , Sequência de Aminoácidos , Sítios de Ligação , Sequência Conservada , Inibidores Enzimáticos/química , Inibidores Enzimáticos/metabolismo , Guanilato Quinases , Dados de Sequência Molecular , Núcleosídeo-Fosfato Quinase/metabolismo , Biblioteca de Peptídeos , Peptídeos/química , Peptídeos/metabolismo , Ligação Proteica , Proteínas/metabolismo , Proteína Supressora de Tumor p53/metabolismo
2.
J Immunol Methods ; 278(1-2): 249-59, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12957412

RESUMO

Scl-70 is the major antigen recognised by autoantibodies in the sera of patients with systemic sclerosis (SSc). The autoantibodies that specifically react with Scl-70 are highly characteristic of the disease and represent valuable markers for the diagnosis of SSc. We describe a novel strategy for cloning autoantibody fragments starting with a small blood sample from an SSc patient. B cells isolated from the collected peripheral blood mononuclear cells (PBMCs) were cultured in vitro using the EL4-B5 system. Anti-Scl-70 IgG-producing cells were pooled for RNA preparation followed by the generation of phagemid libraries of approximately 10(7) independent single-chain Fvs (scFvs). The screening of these libraries by phage display allowed us to isolate four anti-Scl-70 scFvs following three rounds of biopanning. About 10 times more starting blood material was needed to generate scFv libraries of similar size from PBMCs of an SSc patient and only two anti-Scl-70 scFvs were isolated after three rounds of phage selection. Together, this work shows that functional autoantibody fragments can be advantageously cloned after in vitro expansion of B cells. The isolated anti-Scl-70 autoantibody fragments represent useful tools for calibrating SSc diagnostic assays.


Assuntos
Autoanticorpos/isolamento & purificação , Linfócitos B/metabolismo , Proteínas Nucleares/imunologia , Biblioteca de Peptídeos , Escleroderma Sistêmico/diagnóstico , Células Cultivadas , Clonagem Molecular , DNA Topoisomerases Tipo I , Ensaio de Imunoadsorção Enzimática , Humanos , Fragmentos de Imunoglobulinas/isolamento & purificação , Região Variável de Imunoglobulina/genética , Ativação Linfocitária , Reação em Cadeia da Polimerase , Escleroderma Sistêmico/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...